Clinical trial
Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat…
NCT00488319 · Janssen Research & Development, LLC, Industry · Completed
Key facts
| NCT number | NCT00488319 |
|---|---|
| Title | Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia. |
| Official title | A 6-Month, Open-Label, Single-Arm Safety Study of Flexibly Dosed Paliperidone Extended Release (1.5 - 12 mg/Day) in the Treatment of Adolescents (12 to 17 Years of Age) With Schizophrenia |
| Lead sponsor | Janssen Research & Development, LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizophrenic Disorders, Psychotic Disorders, Dementia Praecox |
| Intervention type | Drug |
| Interventions | Paliperidone ER |
| Enrollment | 400 |
| Start date | Jun 1, 2007 |
| Primary completion | Jul 1, 2012 |
| Completion | Jul 1, 2012 |
| First posted | Jun 20, 2007 |
| Last update posted | Feb 10, 2017 |
| Countries | Belgium, Bulgaria, Estonia, Finland, India, Poland, Romania, Russia, South Korea, Ukraine, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: